SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kraig Biocraft Laboratories, Inc – ‘8-K’ for 12/17/13

On:  Thursday, 12/19/13, at 4:08pm ET   ·   For:  12/17/13   ·   Accession #:  1354488-13-6955   ·   File #:  333-146316

Previous ‘8-K’:  ‘8-K’ on 11/22/13 for 11/15/13   ·   Next:  ‘8-K’ on 10/3/14 for 10/2/14   ·   Latest:  ‘8-K’ on / for 4/1/24   ·   43 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/19/13  Kraig Biocraft Laboratories, Inc  8-K:3,5,9  12/17/13    2:901K                                   Issuer Direct/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     20K 
 2: EX-3.1      Articles of Amendment                               HTML      6K

8-K   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 17, 2013

Kraig Biocraft Laboratories, Inc.
(Exact name of Registrant as specified in charter)
 
Wyoming
  
333-146316
  
83-0459707
(State of Incorporation)
  
(Commission File No.) 
  
(IRS Employer Identification Number)
 
120 N. Washington Square, Suite 805, Lansing, Michigan
  
48933
(Address of principal executive offices)
  
(Zip Code)
 
Registrant's telephone number, including area code: (517) 336-0807

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o  
Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

o  
Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

o  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

o  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
 
 
 
 
 
 
Item 3.02 Unregistered Sales of Equity Securities.

Reference is made to the disclosure set forth under Item 3.03 of this report, which disclosure is incorporated herein by reference. The Company issued these securities in reliance on the exemption from registration provided by Section 4(2) of the Securities Act of 1933 Act and Regulation D promulgated thereunder. This current report on Form 8-K does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitution an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful.

Item 3.03 Material Modification to Rights of Security Holders

Effective December 17, 2013, Kraig Biocraft Laboratories, Inc., a Wyoming corporation (the “Company”) amended its Articles of Incorporation to designate Series A of the Company’s preferred stock, no par value. Under the amendment, there are two shares of Series A preferred stock authorized.

The holder of each share of the Series A preferred stock is entitled to vote together with the holders of the Company’s common stock on all matters upon which the Company’s stockholders may vote.  Each share of Series A preferred stock is entitled to 200,000,000 votes on all such matters. Each share of Series A Preferred Stock is convertible into one share of the Company’s common stock at the holder’s option.  On December 19, 2013, the Company issued two shares of Series A preferred stock to Kim Thompson, the Company’s founder and CEO.

The shares of Series A preferred were issued to Mr. Thompson in exchange for an agreement to extend to October, 30, 2014 the date on which the Company would pay certain debts owed to Mr. Thompson.  As part of the transaction, Mr. Thompson also agreed to forgive $30,000.00 (thirty thousand dollars) which the Company owed to him as compensation.

The foregoing description of the Articles of Amendment is qualified in its entirety by the text of the amendment annexed hereto as Exhibit 3.1.

Item 5.03   Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year

Reference is made to the disclosure set forth under Item 3.03 of this report, which disclosure is incorporated herein by reference.
 
Item 9.01    Financial Statements and Exhibits.

(d)      The following exhibits are filed with this report:
 
Exhibit No.
  
Description
     
3.1
  
Articles of Amendment
 
 
 
2
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Kraig Biocraft Laboratories, Inc.
  
       
Dated: December 19, 2013
By:
/s/ Kim Thompson
  
   
Name: Kim Thompson
  
   
Title: Chief Executive Officer
  

 

 
3
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:12/19/13None on these Dates
For Period End:12/17/13
 List all Filings

43 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/14/24  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/24   60:5.8M                                   M2 Compliance LLC/FA
 4/01/24  Kraig Biocraft Laboratories, Inc. 10-K       12/31/23   75:8.1M                                   M2 Compliance LLC/FA
11/22/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
11/16/23  Kraig Biocraft Laboratories, Inc. 424B3                  1:878K                                   M2 Compliance LLC/FA
11/13/23  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/23   66:7.4M                                   M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. POS AM                67:13M                                    M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
 8/14/23  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/23   66:7.4M                                   M2 Compliance LLC/FA
 6/06/23  Kraig Biocraft Laboratories, Inc. S-1/A                 66:13M                                    M2 Compliance LLC/FA
 5/18/23  Kraig Biocraft Laboratories, Inc. 424B3                  1:739K                                   M2 Compliance LLC/FA
 5/12/23  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/23   65:7.3M                                   M2 Compliance LLC/FA
 5/09/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/27/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.9M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. POS AM                65:9.1M                                   M2 Compliance LLC/FA
 3/29/23  Kraig Biocraft Laboratories, Inc. 10-K       12/31/22   70:8.7M                                   M2 Compliance LLC/FA
12/01/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:14M                                    M2 Compliance LLC/FA
11/17/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:1.1M                                   M2 Compliance LLC/FA
11/14/22  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/22   64:7.2M                                   M2 Compliance LLC/FA
 8/12/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:858K                                   M2 Compliance LLC/FA
 8/01/22  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/22   63:6.8M                                   M2 Compliance LLC/FA
 5/25/22  Kraig Biocraft Laboratories, Inc. S-1/A                 64:12M                                    M2 Compliance LLC/FA
 5/10/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:736K                                   M2 Compliance LLC/FA
 5/06/22  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/22   64:6.3M                                   M2 Compliance LLC/FA
 4/14/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:10M                                    M2 Compliance LLC/FA
 3/23/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.7M                                   M2 Compliance LLC/FA
 3/16/22  Kraig Biocraft Laboratories, Inc. 10-K       12/31/21   69:9.6M                                   M2 Compliance LLC/FA
 2/10/22  Kraig Biocraft Laboratories, Inc. S-1                   67:13M                                    M2 Compliance LLC/FA
12/03/21  Kraig Biocraft Laboratories, Inc. S-1/A                 64:13M                                    M2 Compliance LLC/FA
11/05/21  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/21   64:7.3M                                   M2 Compliance LLC/FA
 8/25/21  Kraig Biocraft Laboratories, Inc. S-1/A                 63:12M                                    M2 Compliance LLC/FA
 8/12/21  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/21   63:6.5M                                   M2 Compliance LLC/FA
 5/26/21  Kraig Biocraft Laboratories, Inc. S-1/A                 86:9.3M                                   M2 Compliance LLC/FA
 5/10/21  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/21   62:4.3M                                   M2 Compliance LLC/FA
 4/15/21  Kraig Biocraft Laboratories, Inc. S-1/A                  1:74K                                    M2 Compliance LLC/FA
 4/14/21  Kraig Biocraft Laboratories, Inc. S-1/A                  2:161K                                   M2 Compliance LLC/FA
 4/05/21  Kraig Biocraft Laboratories, Inc. S-1                   63:6M                                     M2 Compliance LLC/FA
 3/12/21  Kraig Biocraft Laboratories, Inc. 10-K       12/31/20   67:5.7M                                   M2 Compliance LLC/FA
 2/18/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
 2/08/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
12/11/20  Kraig Biocraft Laboratories, Inc. 8-A12G                 2:546K                                   M2 Compliance LLC/FA
11/10/20  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/20   57:4.8M                                   M2 Compliance LLC/FA
 8/24/20  Kraig Biocraft Laboratories, Inc. S-1/A                 68:7.8M                                   M2 Compliance LLC/FA
↑Top
Filing Submission 0001354488-13-006955   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 10:07:13.2am ET